US to resume J&J COVID vaccinations despite rare clot risk ...Egypt

EGYPT INDEPENDENT - News
US to resume J&J COVID vaccinations despite rare clot risk
U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized. But ultimately, federal health officials decided that J&J’s one-and-done vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative. The Centers f

Hence then, the article about us to resume j j covid vaccinations despite rare clot risk was published today ( ) and is available on EGYPT INDEPENDENT ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US to resume J&J COVID vaccinations despite rare clot risk )

Apple Storegoogle play

Last updated :

Also on site :